SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-14-007662
Filing Date
2014-01-10
Accepted
2014-01-10 13:31:32
Documents
1
Group Members
JACOB GOTTLIEBJG ASSET, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d659085dsc13g.htm SC 13G 85298
  Complete submission text file 0001193125-14-007662.txt   86961
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87033 | Film No.: 14521189
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE - 22ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE - 22ND FLOOR NEW YORK NY 10019 212-474-8800
Visium Asset Management, LP (Filed by) CIK: 0001377452 (see all company filings)

IRS No.: 203313013 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G